About PPLadmin

This author has not yet filled in any details.
So far PPLadmin has created 11 blog entries.

Dr. Lawrence Toll Presents at NCATS-Sponsored Symposium


Phoenix PharmaLabs is very pleased to announce that our chief neuropharmacologist and co-founder, Dr. Lawrence Toll, will present a poster entitled: “In Vitro and In Vivo Profile of PPL-103: A Mixed Opioid Partial Agonist Analgesic or Drug Abuse Medication”, at the upcoming National Center for Advancing Translational Sciences (NCATS)-sponsored symposium The Opioid Crisis and the Future of Addiction [...]

Dr. Lawrence Toll Presents at NCATS-Sponsored Symposium2019-08-01T19:08:02+00:00

Lilly Joins the Push for Non-Opioid Painkillers


In Pharma Lilly joins the push for non-opioid painkillers 03-Jun-2019 By Maggie Lynch Eli Lilly acquires exclusive worldwide rights for non-opioid treatment for chronic pain from Centrexion through a licensing agreement. HTTPS://WWW.IN-PHARMATECHNOLOGIST.COM/ARTICLE/2019/06/03/ELI-LILLY-LICENSES-NON-OPIOID-TREATMENT-FOR-47.5M 

Lilly Joins the Push for Non-Opioid Painkillers2019-08-02T18:26:46+00:00

Pain Medicine is Evolving – A Non-Addictive Opioid?


A non-addictive opioid under development by Phoenix PharmaLabs (Utah), PPL-103, has demonstrated the potential to be a treatment for opioid, as well as cocaine, addictions, as published in a poster by Lawrence Toll, PhD, professor of biomedical science at the Charles E. Schmidt College of Medicine at Florida Atlantic University, and chief neuropharmacologist of Phoenix [...]

Pain Medicine is Evolving – A Non-Addictive Opioid?2019-08-01T19:10:49+00:00

Phoenix Pharma Labs Technology Transfer Grant


Phoenix PharmaLabs has received a Technology Transfer Grant from the National Institutes of Health to evaluate its lead compound as a potential treatment for cocaine addiction. Dr. Larry Toll, our CTO, was recruited earlier this year by Florida Atlantic University to become the University's first recruit under the 21st Century World Class Scholars Program established [...]

Phoenix Pharma Labs Technology Transfer Grant2018-08-14T18:33:22+00:00
Load More Posts